Ligand validation:6ZIR

EZZ: (3~{S})-3-[2-[(dimethylamino)methyl]-1~{H}-indol-3-yl]-5-oxidanyl-2,3-dihydroisoindol-1-one

EZZ is a Ligand Of Interest in 6ZIR designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZIR_EZZ_A_204	90%	58%	0.072	0.954	1.05	0.54	1	-	0	0	100%	1
6ZIR_EZZ_A_205	88%	59%	0.075	0.952	1.07	0.5	1	-	0	0	100%	1
6ZIZ_EZZ_A_203	79%	50%	0.093	0.937	1.1	0.85	1	2	0	0	100%	1
6GJ6_EZZ_A_204	89%	60%	0.069	0.949	1.02	0.49	1	-	1	0	100%	1
6ZL3_EZZ_A_203	73%	57%	0.103	0.931	1.12	0.55	2	-	0	0	100%	1
6ZJ0_EZZ_A_204	49%	56%	0.132	0.879	1.12	0.56	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.